RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS

被引：0
|
作者：
Kawaguchi, Yasunori
Otsuka, Taiga
Yoshioka, Wataru
Noge, Shotaro
Takahashi, Hirokazu
Eguchi, Yuichiro
Ozaki, Iwata
Okada, Michiaki
Yanagita, Kimihiko
Kohira, Toshikazu
Ide, Yasushi
Yasutake, Tsutomu
Kawasoe, Hiroaki
Mizuta, Toshihiko
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33701-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1530
引用
收藏
页码：S1099 / S1099
页数：1
相关论文
共 50 条
  • [31] Disappearance of perihepatic lymph node enlargement after hepatitis C viral eradication with direct-acting antivirals
    Hikita, H.
    Sato, Masaya
    Endo, Momoe
    Sato, Mamiko
    Soroida, Y.
    Kobayashi, T.
    Gotoh, H.
    Iwai, T.
    Nakagomi, R.
    Tateishi, R.
    Komuro, T.
    Sone, S.
    Koike, K.
    Yatomi, Y.
    Ikeda, H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (04) : 329 - 334
  • [32] Hepatitis C and monoclonal gammopathy of undetermined significance: clinical and hematological outcome after eradication with direct acting antivirals
    Stasio, Rosa Claudia
    Bretto, Elisabetta
    Tizzani, Marco
    Lasco, Roberta
    Troshina, Yulia
    Scaioli, Giacomo
    Pittaluga, Fabrizia
    Saracco, Giorgio Maria
    Ciancio, Alessia
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1200 - S1200
  • [33] Patients with cirrhosis show an improvement in dynamic liver function following the eradication of hepatitis C virus with direct acting antivirals
    Mecci, Jibran
    Kemos, Polychronis
    Foster, Graham
    JOURNAL OF HEPATOLOGY, 2021, 75 : S790 - S791
  • [34] Improvement of sexuality after hepatitis C cure with direct acting antivirals
    Marino, Zoe
    Rodriguez-Tajes, Sergio
    Bartres, Concepcio
    Nacar, Loreto
    Lens, Sabela
    Navines, Ricard
    Cavero, Myriam
    Londono, Maria C.
    Sastre, Lydia
    Pocurull, Anna
    Dafieno, Angella
    Martin-Santos, Rocio
    Forns, Xavier
    LIVER INTERNATIONAL, 2020, 40 (12) : 2972 - 2977
  • [35] The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals
    Seko, Yuya
    Moriguchi, Michihisa
    Takahashi, Aya
    Okishio, Shinya
    Kataoka, Seita
    Okuda, Keiichiroh
    Mizuno, Naoki
    Takemura, Masashi
    Taketani, Hiroyoshi
    Umemura, Atsushi
    Nishikawa, Taichiro
    Yamaguchi, Kanji
    Itoh, Yoshito
    INTERNAL MEDICINE, 2020, 59 (15) : 1811 - 1817
  • [36] Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals
    Tani, Joji
    Masaki, Tsutomu
    Oura, Kyoko
    Tadokoro, Tomoko
    Morishita, Asahiro
    Kobara, Hideki
    MICROORGANISMS, 2024, 12 (09)
  • [37] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
    Harrod, Elizabeth
    Agarwal, Ritu
    Tabrizian, Parissa
    Rayapudi, Madhavi
    Ala, Aftab
    Fiel, Isabel
    Schwartz, Myron
    Dieterich, Douglas
    Friedman, Scott
    Saberi, Behnam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
  • [38] Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis
    Fabrizi, Fabrizio
    Donato, Francesca M.
    Messa, Piergiorgio
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2017, 40 (10): : 531 - 541
  • [39] Direct Acting Antivirals in Hepatitis C Virus Genotype 3 and Advanced Cirrhosis
    Singh, Virendra
    Kumari, Sunita
    Verma, Nipun
    Kumar, Pramod
    De, Arka
    HEPATOLOGY, 2017, 66 : 829A - 829A
  • [40] Hepatitis C virus vaccines in the era of new direct-acting antivirals
    Shi, Chao
    Ploss, Alexander
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 7 (02) : 171 - 185
12345